Labcorp Holdings Inc. LH, or Labcorp, is slated to report its third-quarter 2024 results on Oct. 24, before the market opens.
LabCorp (NYSE:LH) coverage was initiated at neutral by Piper Sandler, which cited a run up in the stock over the past six ...
NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announced ...
LH is well-placed for long-term success in Cell & Gene Therapy, expanding into the consumer market and international growth ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Shares of Labcorp Holdings Inc. LH inched 0.21% higher to $216.85 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.77% to ...